GIVES ME (MENO)PAUSE
Medical startups focus on menopause
The healthcare industry has begun to expand their telemedicine practices into women’s health, with a focus specifically on women going through menopause. Although not life threatening, the symptoms of menopause can take a large toll on day-to-day life and 55% of women don’t address their symptoms. This easy access to information and assistance from physicians helps normalize a process that all females experience at some point.
Healthcare startup Ro recently launched a new vertical completely dedicated to addressing menopause in telehealth. Rory is a telemedicine community created for women aged 45-65 to provide info and care on all topics around menopause and its symptoms. Rory not only offers medical attention from a physician, but a safe space for women to discuss their common health conditions. Users can talk to physicians via video chat and also receive prescriptions and over-the-counter treatments for their symptoms. Appointments are affordable, starting at $13 for over-the-counter appointments and $15 for video chats.
Seattle-based telehealth program genneve launched its services to provide menopause counsel to women. The program targets Gen X women and seeks to alter behaviors around menopause early on. Women can expect hygiene products, an online clinic, podcasts, and an assessment to help them determine where along the menopause journey they are currently. Not only does this program benefit patients, it also gives physicians more flexibility and the opportunity to take work from home. Users can book appointments online, which run $45 to speak with a nurse practitioner and $65 for a physician.
KaNDy is a clinical-stage company that dedicates its research to treatments for chronic debilitating menopause symptoms. The health firm has moved into a phase 2b trial of a nonhormonal therapy that will treat postmenopausal vasomotor symptoms such as hot flashes and sleeplessness. These symptoms affect 75% of women going through menopause and can last one to two years after menopause has ended. The success of this treatment would be a major breakthrough and allow women to choose an alternative to hormone replacement therapy, which studies show can lead to breast cancer, heart disease, stroke, and blood clots.
Have you heard the latest episode of The Cassandra Daily Podcast? Listen and subscribe here.